NICE guidance states that patients with exacerbations of COPD should receive treatment on intensive care units ... as did 5% (38/745) of all inpatient deaths and 3% (44/1289) of all those who died ...

Background Previous models of Hospital at Home (HAH) for COPD exacerbation (ECOPD ... 90% of patients across both arms stated they would prefer HAH treatment during future exacerbations of similar ...

Tezepelumab did not significantly decrease moderate or severe COPD exacerbations compared with placebo, the COURSE trial found.

Among patients with COPD who experienced an exacerbation, the risk for cardiovascular events was highest in the following 2 weeks and stayed elevated more than 1 year after, according to study results ...

Conclusion. In the treatment of COPD exacerbations, systemic corticosteroids improve airflow limitations, decrease treatment failure rates, decrease the risk of relapse, and may improve symptoms ...

Explore strategies for controlling COPD and improving health, with a focus on management and lifestyle changes.

A recent trial showed that nicotinamide riboside supplementation might reduce airway inflammation in patients with COPD who ...

“Patients with mild-to-moderate COPD who have low exercise tolerance are likely to experience poor respiratory health outcomes,” the investigators concluded. “Exercise tolerance may be considered one ...

Study reveals the Prospector calculator reduces antibiotic prescriptions in COPD exacerbations, improving outcomes and ...

The success of Dupixent has demonstrated the viability of biologics in COPD ... the way for a new treatment paradigm, targeting specific inflammatory pathways to reduce exacerbations and improve ...